F 0580
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Immediately tell the resident, the resident's doctor, and a family member of situations (injury/decline/room,
etc.) that affect the resident.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and resident representative and staff interview, the facility failed to notify the
resident's representative when medications were not available for administration. This affected one (#17) of
five residents review for unnecessary medication. The census was 88.
Findings include:
Review of the medical record for Resident #17 revealed the resident was admitted to the facility on [DATE]
at 5:07 P.M. Diagnoses include seizures, idiopathic epilepsy, venous thrombosis, protein calorie
malnutrition, chronic respiratory failure, dysphagia, malformation of brain, disorder of psychological
development, repeated falls, hypertension, and, ataxia.
Review of an admission minimum data set (MDS) assessment dated [DATE] revealed Resident #17
required extensive assist of one person for bed mobility, locomotion, and walking. The resident required
extensive assistance of two for transfers and was dependent upon staff for dressing and eating. A brief
interview of mental status was not completed because the resident was rarely/never understood. The
assessment revealed the resident had long term memory problems and was not able to recall the current
season, location of own room, staff names/faces, or the he/she was in a nursing home.
Review of a medication administration record (MAR) dated 02/20 revealed the medications prescribed to be
administered to Resident #17 on 02/19/20 at 9:00 P.M. were unavailable. The medication identified as
unavailable for administration included lacosamide tablet (anticonvulsant) 200 milligram (mg); ativan
(anticonvulsant/antianxiety) one mg, Phenobarbital tablet (anticonvulsant) 64.8 mg; phenytoin sodium
(anticonvulsant) 100 mg with 30 mg give two capsules (total of 160 mg); Eliquis (anticoagulant) five mg;
Losartan potassium (antihypertensive) 25 mg; and Mucinex (expectorant) 600 mg. Continued review of the
MAR revealed ativan one mg was not available to be administered on 02/20/20 at 9:00 P.M.
Review of the medical record for Resident #17 revealed there was no evidence of the representative for
Resident #17 being notified of medications that were not administered on 02/19/20 or 02/20/20.
Interview on 03/03/20 at 11:37 A.M. with two of Resident #17's representatives revealed the facility did not
notify the representatives of the medications which were unavailable for administration on 02/19/20 and
02/20/20.
Interview on 03/05/20 at 2:42 P.M. with the Director of Nursing (DON) verified the medical record for
Resident #17 contained no evidence the resident's representatives were notified of the medication
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
366000
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366000
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sycamorespring of Miamisburg
2164 E Central Ave
Miamisburg, OH 45342
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0580
not administered to the resident on 02/19/20 and 02/20/20.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366000
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366000
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sycamorespring of Miamisburg
2164 E Central Ave
Miamisburg, OH 45342
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, staff interview, policy review and review of medication information from Medscape,
the facility failed to ensure a resident was free from unnecessary medications when the staff failed to follow
physician ordered parameters regarding the administration of a cardiac medication. This affected one (#29)
of five residents reviewed for unnecessary medications. The facility census was 88.
Residents Affected - Few
Findings included:
Medical record review for Resident #29 revealed an admission date of 08/30/19. Medical diagnoses
included hypertension and cerebrovascular accident with impairment to left side.
Review of quarterly Minimum Data Set (MDS) dated [DATE] revealed she cognitively intact. Functional
status was total dependence for bed mobility and transfers with two-person assistance. She was total
dependence for toilet use with one-person assistance and supervision for eating with set-up help.
Review of physician orders dated 08/31/19 revealed Cardizem 24-hour to give 240 milligrams (mg) by
mouth in the morning for hypertension and hold if pulse was less than 70 beats per minute (bpm).
Review of Medication Administration Record (MAR) from 12/01/19 through 12/31/19 for Resident #29
revealed there were nine dates the Cardizem was administered where the pulse was less than 70 bpm.
Those dates were 12/10/19, 12/11/19, 12/14/19, 12/15/19, 12/16/19, 12/24/19, 12/27/19, 12/28/19 and
12/29/19. Further review of the MAR from 01/01/20 through 01/31/20 revealed there were ten dates the
medication was administered with a pulse documented less than 70 bpm. Those dates were 01/01/20,
01/02/20, 01/04/20 ,01/06/20, 01/07/20, 01/10/20, 01/11/20, 01/12/20, 01/14/20, and 01/31/20. Review of
the MAR from 02/01/20 through 02/29/20 revealed there was ten times the medication was given with a
pulse less than 70. Those dates were 02/02/20, 02/06/20, 02/08/20, 02/12/20, 02/15/20, 02/19/20,
02/20/20, 02/22/20, 02/26/20 and 02/27/20.
Interview with the Director of Nursing (DON) on 03/05/20 at 10:28 A.M. verified the above mentioned dates
the Cardizem was given during the time frame to the resident with a pulse of less than 70.
Review of policy entitled Change of Condition revised 06/01/15 revealed the facility staff will reported
identified significant changes in resident's status. Documentation of the condition will be noted in the
nursing notes or interdisciplinary charting. The resident's physician will be notified of significant changes in
the resident's condition.
Review of medication information from Medscape revealed Cardizem is a cardiac medication used to treat
angina (chest pain), hypertension, paroxysmal supraventricular tachycardia (fast heart beat) and atrial
fibrillation/flutter
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366000
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366000
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sycamorespring of Miamisburg
2164 E Central Ave
Miamisburg, OH 45342
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, cubex (emergency medication box) supply list review, staff, Nurse Practitioner and
physician interviews, policy review and review of medication information from Medscape, the facility failed
administer medications as ordered by the physician resulting in significant medication errors. This affected
one (#17) of five residents review for unnecessary medication. The census was 88.
Residents Affected - Few
Findings include:
Review of the medical record for Resident #17 revealed the resident was admitted to the facility on [DATE]
at 5:07 P.M. Diagnoses include seizures, idiopathic epilepsy, venous thrombosis, protein calorie
malnutrition, chronic respiratory failure, dysphagia, malformation of brain, disorder of psychological
development, repeated falls, hypertension, and, ataxia.
Review of an admission minimum data set (MDS) assessment dated [DATE] revealed Resident #17
required extensive assist of one person for bed mobility, locomotion, and walking. The resident required
extensive assistance of two for transfers and was dependent upon staff for dressing and eating. A brief
interview of mental status was not completed because the resident was rarely/never understood. The
assessment revealed the resident had long term memory problems and was not able to recall the current
season, location of own room, staff names/faces, or the he/she was in a nursing home.
Review of a medication administration record (MAR) dated 02/20 revealed the medications prescribed to be
administered to Resident #17 on 02/19/20 at 9:00 P.M. were unavailable. The medication identified as
unavailable for administration included lacosamide tablet (anticonvulsant) 200 milligram (mg); ativan
(anticonvulsant/antianxiety) one mg, Phenobarbital tablet (anticonvulsant) 64.8 mg; phenytoin sodium
(anticonvulsant) 100 mg with 30 mg give two capsules (total of 160 mg); Eliquis (anticoagulant) five mg;
Losartan potassium (antihypertensive) 25 mg; and Mucinex (expectorant) 600 mg. Continued review of the
MAR revealed ativan one mg was not available to be administered on 02/20/20 at 9:00 P.M.
Review of a document titled, Cubex Formulary undated revealed the medications Eliquis 2.5 mg (supply of
eight), Mucinex 600 mg (supply of 10), Phenobarbital 32.4 mg (supply of 10), phenytoin 100 mg (supply of
six), phenytoin 50 mg chew tablet (supply of five), ativan one mg (supply of two), Losartan 25 mg (supply of
10) where listed as available for resident use in the facilities emergency medication supply. The only
medication not listed as available in the emergency medication supply was lacosamide.
Interview on 03/04/20 at 8:33 A.M. with the Director of Nursing (DON) revealed when a resident was
admitted to the facility and had physician ordered medication due for administration, the medications could
be obtained from the facilities emergency medication supply. The DON further revealed if a medication was
not available in the emergency box supply then the physician would be notified for further direction.
Continued interview with the DON revealed the code 16, when documented on a residents MAR, indicated
the medication was not available from pharmacy. The DON verified documentation on the MAR dated 02/20
for Resident #17 revealed medications scheduled at 9:00 P.M. on 02/19/20, which included ativan one mg;
Phenobarbital 64.8 mg; phenytoin sodium 160 mg; lacosamide 200 mg; Eliquis 5 mg; Losartan potassium
25 mg; and Mucinex 600 mg was not not available from pharmacy. The DON further verified the ativan
scheduled on 02/20/20 at 9:00 P.M. was documented as unavailable. The DON confirmed the medications
that were documented as unavailable on 02/19/20 and 02/20/20 were not
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366000
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366000
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sycamorespring of Miamisburg
2164 E Central Ave
Miamisburg, OH 45342
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
administered to Resident #17. Continued interview with the DON verified six of the seven medications that
were documented on the resident MAR as unavailable, were identified on the cubex formulary and available
in the emergency medication supply.
Interview on 03/04/20 at 8:58 A.M. with Physician #239 (Resident #17 primary care physician) revealed
when medication were available in the facilities emergency supply and there was a valid prescription, it
would be expect that the medications would be administered. Interview with the physician revealed the only
medication that should have been held for Resident #17 on 02/19/20 at 9:00 P.M. was the lacosamide,
because it was not available in the emergency box. Continued interview with Physician #239 revealed on
this day, 03/04/20, the facility spoke with this physician in regards to the medications that were placed on
hold on 02/19/20 by the on call nurse practitioner. The interview revealed it was this physician's professional
opinion that the available medications should have been administered as ordered. Interview with the
physician revealed the physician was made aware of the 02/19/20 medications being placed on hold on
03/04/20 and the physician was asked to sign the telephone ordered for the held medication on 03/04/20,
even though the telephone order indicated the order was signed by this physician on 02/19/20. The
physician did not know who documented the sign date as 02/19/20.
Interview 03/04/20 at 10:37 A.M. with Nurse Practitioner (NP) #238 (on call for Physician #239 on 02/19/20)
revealed facility staff called the NP on 02/19/20, and a verbal order was given to hold unavailable
medications until they were available the next morning. Interview with NP #238 revealed the NP was not
aware of the facility having an emergency medication supply. Further interview with the NP revealed it was
the NP's expectation that any medications which had a valid order and was available in the emergency
supply would be administered to Resident #17 and not be held until the next morning.
Review of a policy titles, Emergency Boxes and On-Site Stores, dated 06/21/17, revealed the pharmacy
supplies an emergency box and other on-site stores of medications to be utilized by he facility in the case of
new admissions, urgent new orders received after hours, or when immediate medication administration was
required. When receiving a new medication order that needs to be administered prior to the next pharmacy
delivery, the nurse obtaining the order should check the on-site store list prior to accepting the order from
the physician to see if that medication is available in the facility. If not, the physician should be informed of
the available medications to determine if an alternative can be ordered.
Review of medication information from Medscape revealed the following: Ativan is used as an antianxiety;
Phenobarbital is an anticonvulsant (anti-seizure); Phenytoin sodium is an anticonvulsant; Eliquis is an
anticoagulant; Losartan is used to treat hypertension and Mucinex is used to treat a cough.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366000
If continuation sheet
Page 5 of 5